<!DOCTYPE html><html prefix="og: http://ogp.me/ns#" lang="zh">
<!-- Mirrored from cn.nytimes.com/business/20200928/china-coronavirus-vaccine/dual/ by HTTrack Website Copier/3.x [XR&CO'2014], Fri, 28 Jan 2022 14:10:49 GMT -->
<!-- Added by HTTrack --><meta http-equiv="content-type" content="text/html;charset=utf-8" /><!-- /Added by HTTrack -->
<head><meta charset="UTF-8"><!-- Browser render  --><meta http-equiv="X-UA-Compatible" content="IE=edge,chrome=1"><meta name="renderer" content="webkit"><!-- End Browser render --><meta name="keywords" content=""><meta name="description" content="尽管目前尚未有疫苗被证明有效，中国政府正在给许多人注射三种国产候选疫苗。未经检验的疫苗可能产生有害副作用；接种过程中的知情同意问题也引发质疑。"><meta id="uuid" name="uuid" content="42e5934eda47d8f41a204c1fa04619e2"><meta id="headline" name="headline" content="中国的新冠疫苗豪赌：风险未知，数万人已接种 - 世界经济观察报中文网"><meta id="byline" name="byline" content="黄瑞黎"><meta id="date" name="date" content="2020-09-28T11:06:42.000Z"><link rel="alternate" href="../index.html" hreflang="zh-Hans"><link rel="alternate" href="../zh-hant/index.html" hreflang="zh-Hant"><link rel="alternate" href="https://www.nytimes.com/2020/09/26/business/china-coronavirus-vaccine.html" hreflang="en-us"><link rel="canonical" href="../index.html"><link rel="alternate" type="application/rss+xml" href="https://cn.nytimes.com/rss/"><meta name="apple-itunes-app" content="app-id=807498298, app-argument=nytimescn://article:42e5934eda47d8f41a204c1fa04619e2"><meta name="lang" property="lang" content="zh-cmn-hans"><!-- Apple IOS safari private meta --><link rel="apple-touch-icon-precomposed" sizes="144×144" href="../../../../../static01.nyt.com/images/icons/ios-ipad-144x144.png"><link rel="apple-touch-icon-precomposed" sizes="114×114" href="../../../../../static01.nyt.com/images/icons/ios-iphone-114x144.png"><link rel="apple-touch-icon-precomposed" href="../../../../../static01.nyt.com/images/icons/ios-default-homescreen-57x57.png"><meta name="apple-mobile-web-app-title" content="中国的新冠疫苗豪赌：风险未知，数万人已接种 - 世界经济观察报中文网"><meta name="apple-mobile-web-app-capable" content="yes"><!-- End Apple IOS safari private meta --><!-- Viewport and mobile --><meta name="viewport" content="width=device-width,initial-scale=1,user-scalable=no,maximum-scale=1,minimum-scale=1,minimal-ui"><!-- End viewport and mobile --><meta http-equiv="Cache-Control" content="no-siteapp"><meta name="format-detection" content="telephone=no"><meta name="HandheldFriendly" content="true"><meta name="MobileOptimized" content="320"><meta name="x5-orientation" content="portrait"><meta name="full-screen" content="yes"><meta name="x5-fullscreen" content="true"><meta name="browsermode" content="application"><meta name="x5-page-mode" content="app"><meta name="msapplication-tap-highlight" content="no"><meta property="og:title" content="中国的新冠疫苗豪赌：风险未知，数万人已接种"><meta property="og:type" content="article"><meta property="og:url" content="../index.html"><meta property="og:description" content="尽管目前尚未有疫苗被证明有效，中国政府正在给许多人注射三种国产候选疫苗。未经检验的疫苗可能产生有害副作用；接种过程中的知情同意问题也引发质疑。"><meta property="og:site_name" content="世界经济观察报中文网"><meta property="article:publisher" content="https://www.facebook.com/nytimeschinese"><meta property="article:published_time" content="2020-09-28T11:06:42.000Z"><meta property="fb:pages" content="354478527979178"><meta property="fb:app_id" content="1752616314982485"><meta property="og:image" content="../../../../../static01.nyt.com/images/2020/09/24/business/00china-vaccines-4/merlin_177506904_a5ef138b-1f68-485e-b337-4f5e28077822-articleLarge.html"><meta property="twitter:card" content="summary_large_image"><meta property="twitter:url" content="../index.html"><meta property="twitter:title" content="中国的新冠疫苗豪赌：风险未知，数万人已接种"><meta property="twitter:description" content="尽管目前尚未有疫苗被证明有效，中国政府正在给许多人注射三种国产候选疫苗。未经检验的疫苗可能产生有害副作用；接种过程中的知情同意问题也引发质疑。"><meta property="twitter:domain" content="cn.nytimes.com"><meta property="twitter:site" content="@nytchinese"><meta property="twitter:creator" content="@nytchinese"><meta property="twitter:image:src" content="../../../../../static01.nyt.com/images/2020/09/24/business/00china-vaccines-4/merlin_177506904_a5ef138b-1f68-485e-b337-4f5e28077822-articleLarge.html"><meta name="PT" content="article"><meta name="PST" content="News"><meta name="CG" content="business"><meta name="SCG" content=""><meta name="sourceApp" content="nyt-china-web"><meta name="ptime" content="20200928110642"><meta name="utime" content="20200928110642"><meta name="pdate" content="20200928"><meta name="dat" content="Sep. 28, 2020"><meta name="hdl" content="中国的新冠疫苗豪赌：风险未知，数万人已接种"><meta name="byl" content="黄瑞黎"><meta name="lp" content="尽管目前尚未有疫苗被证明有效，中国政府正在给许多人注射三种国产候选疫苗。未经检验的疫苗可能产生有害副作用；接种过程中的知情同意问题也引发质疑。"><link rel="shortcut icon" href="https://static01.nyt.com/favicon.ico"><link rel="stylesheet" href="../../../../../d1f1eryiqyjs0r.cloudfront.net/style/css/nytcn_core/style-flex.min619b.css?v=f1810d8"><link rel="stylesheet" href="../../../../../d1f1eryiqyjs0r.cloudfront.net/style/css/web/style.min619b.css?v=f1810d8"><link rel="stylesheet" href="../../../../../d1f1eryiqyjs0r.cloudfront.net/style/css/nytcn_core/article.min619b.css?v=f1810d8"><link rel="stylesheet" href="../../../../../d1f1eryiqyjs0r.cloudfront.net/style/css/slideshow/slideshow.min619b.css?v=f1810d8"><link rel="stylesheet" href="../../../../../d1f1eryiqyjs0r.cloudfront.net/style/css/cookie-banner/style.min619b.css?v=f1810d8"><title>中国的新冠疫苗豪赌：风险未知，数万人已接种 - 世界经济观察报中文网</title></head><script>var js_static_path = "https://d1f1eryiqyjs0r.cloudfront.net/js";
 var imgs_static_path = "https://d1f1eryiqyjs0r.cloudfront.net/style/imgs";
 var style_static_path = "https://d1f1eryiqyjs0r.cloudfront.net/style";
 var site = 1;
 var sectionName = "business";
 var adTyp = "art";
 var cookieString = {
     "title": "您的跟踪器设置",
     "headline": "我们使用 cookie 做什么？",
     "summary": '<p>我们利用cookies和类似的技术识别您的重复访问和偏好。我们还使用它们来衡量广告系列的效果，定位广告并分析和网站流量。更多关于cookies的信息（包括如何停用），<a id="JSCookiePolicyLink" href="https://www.nytimes.com/zh-hans/privacy/cookie-policy" rel="noreferrer noopener" target="_blank" data-testid="GDPR-policy">请查看我们的“Cookie政策”</a>。</p><p>自2020年7月20日起，我们将根据您在我们服务中所访问的内容类型向您显示我们认为与您的兴趣相关的广告。您可以<a href="https://www.nytimes.com/zh-hans/privacy/cookie-policy#how-do-i-manage-trackers" rel="noreferrer noopener" target="_blank" data-testid="GDPR-objection">提出反对</a>。希望了解更多信息，请参见我们的<a href="https://nytimes.com/zh-hans/privacy/privacy-policy#we-allow-for-personalized-advertising-on-times-services" rel="noreferrer noopener" target="_blank" data-testid="GDPR-privacy">隐私政策</a>。</p><p>通过在此处点击“我接受”或者“X”，您将被视为同意使用cookies。您随时可以通过我们的Cookie政策来更改您的跟踪器偏好。</p>',
     "button": "接受",
     "trackerButton": "您的跟踪器设置",
     "rejectButton": "拒绝所有",
     "lang": 'zh-hans',
     "trackerLink": "https://www.nytimes.com/zh-hans/privacy/cookie-policy",
 };
 var purrString = {
     "button": "请勿出售我的个人信息",
     "snackbar": "你的设置已经保存在此浏览器和设备上。如果你清除了 cookie，这些设置也会被清除。",
     "snackbarError": "Something went wrong",
     "optedOutText": "我们不再出售您的个人信息",
     "CFALinkText": "California Notices",
     "purrPopupTitle": "Your request to not sell your data will be stored for this browser and device",
     "purrPopupSummary": "If you clear your cookies, your preference will be forgotten. As a California resident, you have additional rights under the California Consumer Privacy Act of 2018. While The New York Times Company does not “sell” personal information of its readers as the term “sell” is traditionally understood, “sell” under the CCPA is broadly defined. To learn more, review the text below.",
     "purrPopupButton": "DISMISS",
     "purrPopupScrollContent": '<p>The New York Times Company does not sell personal information of its readers as the term “sell” is traditionally understood. But “sell” under the CCPA is broadly defined. It includes the sharing of personal information with third parties in exchange for something of value, even if no money changes hands. For example, sharing an advertising or device identifier to a third party may be considered a “sale” under the CCPA. </p><p>To the extent The New York Times Company “sells” your personal information (as the term “sell” is defined under the CCPA), you have the right to opt-out of that “sale” on a going-forward basis at any time. To exercise this right, click the “Do Not Sell My Personal Information” link in the footer of our website or under your “Account,” which you have already done. You can also submit a request to opt-out by emailing us at privacy@nytimes.com with the subject line “California Resident - Do Not Sell.”</p><p>Once you have opted out, you will see a change to “We No Longer Sell Your Personal Information.” If you have an account with certain Times Services (specifically nytimes.com, cooking.nytimes.com, nytimes.com/crosswords, the New York Times app, the New York Times Cooking app and the New York Times Crossword app) and are logged in, we will save your preference and honor your opt-out request across browsers and devices so long as you remain logged in. If you are not logged in, or do not have an account with any Times Services listed above, your opt-out of the “sale” of personal information will be specific to the browser or device from which you have clicked “Do Not Sell My Personal Information” and until you clear your cookies (or local storage in apps) on this browser or device. </p><p>If your browser or device is using a “do not track” setting, we will detect it and honor it on that specific browser or device only. If you wish to have a “do not track” experience across all of your browsers and devices, please make sure that all of your browsers and devices are set on “do not track.”</p><p>After you opt out of the “sale” of your personal information, we will no longer “sell” your personal information to third parties (except in an aggregated or de-identified manner so it is no longer personal information), but we will continue to share your personal information with our service providers, which process it on our behalf. Exercising your right to opt out of the “sale” of your personal information does not mean that you will stop seeing ads on our sites and apps. </p><p>To opt-out of interest-based advertising as much as technically possible, go to <a href="http://www.nytimes.com/privacy/cookie-policy#how-do-i-manage-trackers" target="_blank">“How Do I Manage Trackers”</a> in our Cookie Policy. To opt out of the “sale” of your personal information from participating companies, please visit the Digital Advertising Alliance <a href="https://optout.privacyrights.info/?c=1" target="_blank">website</a> or <a href="https://www.privacyrights.info/appchoices" target="_blank">apps</a>. We do not control these opt-out mechanisms and are not responsible for their operation.</p><p>You can designate someone else to make a request on your behalf. To protect your information, we will ask for a signed permission from you authorizing the other person to submit a request on your behalf. We will contact you to verify your identity before we respond to your authorized agent’s request.<p/><p>After 12 months, we may ask you if you want to opt into the “sale” of your personal information.</p><p>For further information, please refer to our <a href="http://www.nytimes.com/privacy/privacy-policy" target="_blank">Privacy Policy.</a></p>',
     "lang": 'zh-hans'
 };
 cbSectionName = "business";
 cbByline = "黄瑞黎";</script><!-- Google Tag Manager --><script>(function(w,d,s,l,i){
     w[l]=w[l]||[];w[l].push({'gtm.start':new Date().getTime(),event:'gtm.js'});
     var f=d.getElementsByTagName(s)[0],j=d.createElement(s),dl=l!='dataLayer'?'&l='+l:'';
     j.async=true;j.src='../../../../../www.googletagmanager.com/gtm5445.html?id='+i+dl;
     f.parentNode.insertBefore(j,f);
 })(window,document,'script','dataLayer','GTM-KTDZV8V');</script><!-- End Google Tag Manager --><!-- chartbeat --><script type="text/javascript">var _sf_startpt=(new Date()).getTime()</script><!-- /chartbeat --><body class="news"><main class="container-fluid main clearfix"><header class="row title-bar"><div class="nav-button default" id="menuBtn"><i class="icon-bars"></i></div><h1 class="logo"><a href="/"><svg role="img" aria-label="" width="90%" height="90%"><image width="100%" height="100%" xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="/d1f1eryiqyjs0r.cloudfront.net/style/imgs/mweb/nytimes-zh-hans%402x.png" src="../../../../../d1f1eryiqyjs0r.cloudfront.net/style/imgs/mweb/nytimes-zh-hans%402x.png" alt="" border="0"></image></svg></a></h1><div class="nav-button default" id="gearBtn"><i class="icon-gear"></i></div><div class="popup gear-popup"><div class="tips-container"><div class="tips-border"></div><div class="tips-inner"></div></div><div class="popup-container"><div class="popup-body"><div class="setting-title">简繁中文</div><div class="setting-option"><a href="../index024e.html?changeLang=zh-hans" class="active">简体 </a><a href="../index27d8.html?changeLang=zh-hant">繁体</a></div><div class="setting-title">世界经济观察报 出版语言</div><ul class="menu-list"><li><a href="https://www.nytimes.com/">ENGLISH (英语)</a></li><li><a href="https://www.nytimes.com/es/">ESPAÑOL (西班牙语)</a></li></ul><div class="setting-title">字体大小</div><div class="setting-option"><div class="form-check form-check-inline"><label class="form-check-label"><input class="form-check-input font-size" type="radio" name="changeFontSizeRadio" value="small"> 小</label></div><div class="form-check form-check-inline"><label class="form-check-label"><input class="form-check-input font-size" type="radio" name="changeFontSizeRadio" value="normal" checked="checked"> 中</label></div><div class="form-check form-check-inline"><label class="form-check-label"><input class="form-check-input font-size" type="radio" name="changeFontSizeRadio" value="large"> 大</label></div><div class="form-check form-check-inline"><label class="form-check-label"><input class="form-check-input font-size" type="radio" name="changeFontSizeRadio" value="xlarge"> 超大</label></div></div></div></div></div></header><div class="top_banner_ad" id="topad" data-target="{&quot;pos&quot;:&quot;top&quot;,&quot;adv&quot;:&quot;&quot;}"></div><div class="article-area"><div class="setting-bar row"><div class="col-4 section-title"><h3>商业与经济</h3></div><div class="col-8 setting-btns"><div class="row"><div class="col-6"><ul class="dual-btn"><li><a href="../index.html"><span class="setting-btn-text">中文</span> <span class="setting-btn-text-mobile">中</span></a></li><li><a href="javascript:;" class="active"><span class="setting-btn-text">中英双语</span> <span class="setting-btn-text-mobile">双语</span></a></li><li><a href="https://www.nytimes.com/2020/09/26/business/china-coronavirus-vaccine.html" target="_blank"><span class="setting-btn-text">英文 <i class="icon-share-square"></i> </span><span class="setting-btn-text-mobile">英</span></a></li></ul></div><div class="col-6 share-tools-top-container"><ul class="share-tools mobile-article"><li><a href="http://v.t.sina.com.cn/share/share.php?&amp;title=%E4%B8%AD%E5%9B%BD%E7%9A%84%E6%96%B0%E5%86%A0%E7%96%AB%E8%8B%97%E8%B1%AA%E8%B5%8C%EF%BC%9A%E9%A3%8E%E9%99%A9%E6%9C%AA%E7%9F%A5%EF%BC%8C%E6%95%B0%E4%B8%87%E4%BA%BA%E5%B7%B2%E6%8E%A5%E7%A7%8D&amp;url=https://cn.nytimes.com/business/20200928/china-coronavirus-vaccine/" target="_blank"><i class="icon-weibo"></i></a></li><!-- <li> --><!-- <a href="javascript:void(0);" class="JS_shareForQrcode" data-url="https://cn.nytimes.com/business/20200928/china-coronavirus-vaccine/" data-headline="%E4%B8%AD%E5%9B%BD%E7%9A%84%E6%96%B0%E5%86%A0%E7%96%AB%E8%8B%97%E8%B1%AA%E8%B5%8C%EF%BC%9A%E9%A3%8E%E9%99%A9%E6%9C%AA%E7%9F%A5%EF%BC%8C%E6%95%B0%E4%B8%87%E4%BA%BA%E5%B7%B2%E6%8E%A5%E7%A7%8D"> --><!-- <i class="icon-wechat"></i> --><!-- </a> --><!-- </li> --><li><a href="https://www.facebook.com/sharer/sharer.php?u=https://cn.nytimes.com/business/20200928/china-coronavirus-vaccine/" trage="_blank"><i class="icon-facebook"></i></a></li><li><a href="https://plus.google.com/share?url=https://cn.nytimes.com/business/20200928/china-coronavirus-vaccine/" target="_blank"><i class="icon-google"></i></a></li><li><a href="https://twitter.com/share?text=%E4%B8%AD%E5%9B%BD%E7%9A%84%E6%96%B0%E5%86%A0%E7%96%AB%E8%8B%97%E8%B1%AA%E8%B5%8C%EF%BC%9A%E9%A3%8E%E9%99%A9%E6%9C%AA%E7%9F%A5%EF%BC%8C%E6%95%B0%E4%B8%87%E4%BA%BA%E5%B7%B2%E6%8E%A5%E7%A7%8D&amp;url=https://cn.nytimes.com/business/20200928/china-coronavirus-vaccine/" target="_blank"><i class="icon-twitter"></i></a></li><li><div class="line-it-button" data-lang="zh_Hant" data-type="share-g" data-url="https://cn.nytimes.com/business/20200928/china-coronavirus-vaccine/" style="display: none;"></div><script src="/d.line-scdn.net/r/web/social-plugin/js/thirdparty/loader.min.js" async="async" defer="defer"></script></li><!-- <li> --><!-- <a href="javascript:void(0);" class="JS_shareForQrcode" data-url="https://cn.nytimes.com/business/20200928/china-coronavirus-vaccine/" data-headline="%E4%B8%AD%E5%9B%BD%E7%9A%84%E6%96%B0%E5%86%A0%E7%96%AB%E8%8B%97%E8%B1%AA%E8%B5%8C%EF%BC%9A%E9%A3%8E%E9%99%A9%E6%9C%AA%E7%9F%A5%EF%BC%8C%E6%95%B0%E4%B8%87%E4%BA%BA%E5%B7%B2%E6%8E%A5%E7%A7%8D"> --><!-- <i class="icon-qrcode"></i> --><!-- </a> --><!-- </li> --></ul><div class="share-btn"><i class="icon-forward"></i></div></div></div></div></div><article class="article-content article-dual font-normal"><div class="article-header"><header><small></small><h1>中国的新冠疫苗豪赌：风险未知，数万人已接种</h1><h1 class="en-title">China Gives Unproven Covid-19 Vaccines to Thousands, With Risks Unknown</h1></header><div class="byline-row"><div class="byline-box"><div class="byline"><address>黄瑞黎</address><time pudate="2020-09-28 11:06:42" datetime="2020-09-28 11:06:42">2020年9月28日</time></div><div class="share-btn"><i class="icon-forward"></i></div></div></div></div><figure class="article-span-photo"><img src="../../../../../static01.nyt.com/images/2020/09/24/business/00china-vaccines-4/merlin_177506904_a5ef138b-1f68-485e-b337-4f5e28077822-master1050.html" width="1050" height="700" alt="北京的制药企业北京科兴生物技术有限公司表示，在北京已有一万多人接种了该公司的新冠肺炎候选疫苗。"><figcaption><span>北京的制药企业北京科兴生物技术有限公司表示，在北京已有一万多人接种了该公司的新冠肺炎候选疫苗。</span> <cite>Wu Hong/EPA, via Shutterstock</cite></figcaption></figure><div class="row"><section class="article-body"><div class="article-partial"><div class="article-body-item col-lg-5"><div class="row article-dual-body-item"><div class="col-lg-6"><div class="article-paragraph">First, <a href="https://www.nytimes.com/2020/07/16/business/china-vaccine-coronavirus.html">workers at state-owned companies got dosed.</a> Then government officials and vaccine company staff. Up next: teachers, supermarket employees and people traveling to risky areas abroad.</div></div><div class="col-lg-6"><div class="article-paragraph">先是<a href="../../../20200717/china-vaccine-coronavirus/index.html">国企的工作人员接种</a>。然后是政府官员和疫苗制造企业的员工。接下来是教师、超市员工和去国外高危地区旅行的人。</div></div></div><div class="row article-dual-body-item"><div class="col-lg-6"><div class="article-paragraph">The world still lacks a proven coronavirus vaccine, but that has not stopped Chinese officials from trying to inoculate tens of thousands, if not hundreds of thousands, of people outside the traditional testing process. Three vaccine candidates are being injected into workers whom the government considers essential, along with many others, including employees of the pharmaceutical firms themselves.</div></div><div class="col-lg-6"><div class="article-paragraph">尽管世界上还没有一种预防新型冠状病毒的疫苗被证明有效，但这并没有阻止中国官员在传统检验程序之外尝试让数万甚至数十万人接种疫苗。政府正在给其认为必不可少的工作人员和许多其他人，包括制药公司自己的员工注射三种候选疫苗。</div></div></div><div class="row article-dual-body-item"><div class="col-lg-6"><div class="article-paragraph">Officials are laying out plans to give shots to even more people, citing emergency use, amounting to a big wager that the vaccines will eventually prove to be safe and effective.</div></div><div class="col-lg-6"><div class="article-paragraph">官员们正在制定紧急使用方案，让更多的人接种疫苗，这相当于一场豪赌，即这些疫苗最终将被证明安全有效。</div></div></div><div class="row article-dual-body-item"><div class="col-lg-6"><div class="article-paragraph">China’s rush has bewildered global experts. No other country has injected people with unproven vaccines outside the usual drug trial process to such a huge scale.</div></div><div class="col-lg-6"><div class="article-paragraph">中国这种急匆匆的做法令全球专家困惑。没有其他国家在常规药物试验程序之外，以如此之大的规模给人们注射未经检验的疫苗。<br></div></div></div></div><div class="article-body-aside col-lg-3"><div id="subscribe_cont" style="margin: 0 auto;" class="container"></div></div></div><div class="big_ad" id="medium-rectangle-ad-0" data-target="{&quot;pos&quot;:&quot;mid1&quot;,&quot;adv&quot;:&quot;&quot;}"><small>广告</small></div><div class="article-partial"><div class="article-body-item col-lg-5"><div class="row article-dual-body-item"><div class="col-lg-6"><div class="article-paragraph">The vaccine candidates are in Phase 3 trials, or the late stages of testing, which are mostly being conducted outside China. The people in those trials are closely tracked and monitored. It is not clear that China is taking those steps for everyone who is getting the shots within the country.</div></div><div class="col-lg-6"><div class="article-paragraph">候选疫苗目前正处于三期，也就是后期临床试验阶段，大多数试验在中国境外进行。参加试验者的情况受到密切的跟踪和观察。目前尚不清楚，中国是否对国内所有注射了疫苗的人采取了类似的跟踪步骤。</div></div></div><div class="row article-dual-body-item"><div class="col-lg-6"><div class="article-paragraph">The unproven vaccines could have harmful side effects. Ineffective vaccines could lead to a false sense of security and encourage behavior that could lead to even more infections.</div></div><div class="col-lg-6"><div class="article-paragraph">未经检验的疫苗可能会产生有害的副作用。无效的疫苗可能会给人带来一种假的安全感，并助长可能导致更多感染的行为。<br></div></div></div><div class="row article-dual-body-item"><div class="col-lg-6"><div class="article-paragraph">The wide use of vaccines also raises issues of consent, especially for employees of Chinese vaccine makers and state-owned companies who might feel pressure to roll up their sleeves. The companies have asked people taking the vaccines to sign a nondisclosure agreement preventing them from talking about it to the news media.</div></div><div class="col-lg-6"><div class="article-paragraph">疫苗的广泛使用也提出了知情同意的问题，尤其是对中国疫苗生产商和国企员工来说，他们可能会有压力，不得不挽起袖子接种疫苗。这些企业已要求接种疫苗的人签署保密协议，不让他们与新闻媒体谈论此事。<br></div></div></div><div class="row article-dual-body-item"><div class="col-lg-6"><div class="article-paragraph">“My worry for the employees of the companies is it may be difficult for them to refuse,” said Dr. Kim Mulholland, a pediatrician at the Murdoch Children’s Research Institute in Melbourne, Australia, who has been involved in the oversight of many vaccine trials, including those for a Covid-19 vaccine.</div></div><div class="col-lg-6"><div class="article-paragraph">“我对这些公司员工的担心是，他们可能很难拒绝接种，”澳大利亚墨尔本默多克儿童研究所(Murdoch Children’s Research Institute)的儿科医生金姆·马尔霍兰(Kim Mulholland)说，他参加过许多疫苗试验的监管，包括一种新冠病毒疫苗试验。</div></div></div><figure class="article-inline-photo large"><div class="img-box"><img src="../../../../../static01.nyt.com/images/2020/09/23/business/00china-vaccines-1/merlin_176604243_18f58f36-f08c-44ac-88e7-63254172e3c1-master1050.html" alt="北京科兴生物技术有限公司在北京的一个展销会上推销疫苗的摊位。" data-src="../../../../../static01.nyt.com/images/2020/09/23/business/00china-vaccines-1/merlin_176604243_18f58f36-f08c-44ac-88e7-63254172e3c1-master1050.html"></div><figcaption><span>北京科兴生物技术有限公司在北京的一个展销会上推销疫苗的摊位。</span> <cite>Lintao Zhang/Getty Images</cite></figcaption></figure><div class="row article-dual-body-item"><div class="col-lg-6"><div class="article-paragraph">While China is racing the United States and other countries to develop a vaccine, its rivals are moving more cautiously. American companies have <a href="https://www.nytimes.com/2020/09/08/health/9-drug-companies-pledge-coronavirus-vaccine.html">pledged</a> to thoroughly vet a vaccine before wide use, despite pressure from President Trump to go faster. In Russia, the first country to approve a vaccine even before trials were completed, the authorities have <a href="https://www.nytimes.com/2020/09/19/world/europe/russia-coronavirus-vaccine.html?smid=tw-share">yet to administer it</a> to a large population, according to health officials and experts.</div></div><div class="col-lg-6"><div class="article-paragraph">中国在疫苗研发上与美国和其他国家展开竞争时，其竞争对手的行动则更为谨慎。尽管有来自特朗普总统要求加快速度的压力，但美国的药企已<a href="https://www.nytimes.com/2020/09/08/health/9-drug-companies-pledge-coronavirus-vaccine.html">承诺</a>在疫苗广泛投入使用之前对其进行彻底的审查。俄罗斯是第一个在试验尚未完成之前就批准了疫苗的国家，但据该国卫生官员和专家说，当局<a href="https://www.nytimes.com/2020/09/19/world/europe/russia-coronavirus-vaccine.html">尚未对</a>大量人群进行疫苗接种。</div></div></div><div class="row article-dual-body-item"><div class="col-lg-6"><div class="article-paragraph">It is not clear how many people in China have received coronavirus vaccines. Sinopharm, a Chinese state-owned company with a vaccine candidate in late-stage trials, has said hundreds of thousands of people have received its shots. Sinovac, a Beijing-based company, said more than 10,000 people in Beijing had been injected with its vaccine. Separately, it said <a rel="noopener noreferrer" target="_blank" href="https://www.scmp.com/news/china/science/article/3100447/chinese-drug-firm-sinovac-says-thousands-employees-and-their">nearly all its employees </a>— around 3,000 in total — and their families had taken it.</div></div><div class="col-lg-6"><div class="article-paragraph">目前不清楚中国已有多少人接种了新冠病毒疫苗。国有企业国药集团的一种疫苗已进入后期试验阶段，该公司称，已有数十万人接种了这种疫苗。北京科兴控股生物技术有限公司说，在北京已有一万多人注射了公司的疫苗。另外，该公司表示，<a rel="noopener noreferrer" target="_blank" href="https://www.scmp.com/news/china/science/article/3100447/chinese-drug-firm-sinovac-says-thousands-employees-and-their">几乎所有员工</a>（约3000人）和他们的家人已接种了疫苗。<br></div></div></div></div><div class="article-body-aside col-lg-3"></div></div><div class="big_ad" id="medium-rectangle-ad-1" data-target="{&quot;pos&quot;:&quot;mid2&quot;,&quot;adv&quot;:&quot;&quot;}"><small>广告</small></div><div class="article-partial"><div class="article-body-item col-lg-5"><div class="row article-dual-body-item"><div class="col-lg-6"><div class="article-paragraph">Hong Kong-based Phoenix Television said this month that its Chinese journalists had been given the Sinopharm vaccine.</div></div><div class="col-lg-6"><div class="article-paragraph">总部设在香港的凤凰卫视本月说，其中国记者已经接种了国药集团的疫苗。<br></div></div></div><div class="row article-dual-body-item"><div class="col-lg-6"><div class="article-paragraph">Tao Lina, a vaccine expert in Shanghai, said part of the government’s motivation was to “test” the public’s willingness to take a vaccine, laying the groundwork for wider acceptance.</div></div><div class="col-lg-6"><div class="article-paragraph">上海的疫苗专家陶黎纳说，政府的部分动机是“试探”公众接受疫苗的意愿，为更广泛的接种打基础。<br></div></div></div><div class="row article-dual-body-item"><div class="col-lg-6"><div class="article-paragraph">“I think this is our country feeling us out,” said Mr. Tao, a former immunologist at the Shanghai Center for Disease Control and Prevention. “That is to say, even without an epidemic, everyone should consider the possibility of a resurgence and weigh whether they want to get a shot or not.”</div></div><div class="col-lg-6"><div class="article-paragraph">“我觉得这个也是我们国家在试探，”曾在上海疾病预防控制中心工作任免疫学家的陶黎纳说。“就是说在疫情没有的情况下，那么大家个人都去考虑一下将来发生疫情的可能性，掂量一下自己到底有没有必要去打。”</div></div></div><figure class="article-inline-photo large"><div class="img-box"><img src="../../../../../static01.nyt.com/images/2020/09/24/business/00china-vaccines-5/00china-vaccines-5-master1050.html" alt="工程师们在北京科兴生物技术有限公司修建的疫苗生产厂房。" data-src="../../../../../static01.nyt.com/images/2020/09/24/business/00china-vaccines-5/00china-vaccines-5-master1050.html"></div><figcaption><span>工程师们在北京科兴生物技术有限公司修建的疫苗生产厂房。</span> <cite>Wang Zhao/Agence France-Presse — Getty Images</cite></figcaption></figure><div class="row article-dual-body-item"><div class="col-lg-6"><div class="article-paragraph">On Friday, Zheng Zhongwei, an official with China’s National Health Commission, said the government had “gained the understanding and support” of the World Health Organization after China’s cabinet approved the emergency use program. A spokesperson for the W.H.O. said on Saturday that China had issued a “domestic emergency use authorization,” which are issued at the discretion of countries and are not subject to W.H.O. approval.</div></div><div class="col-lg-6"><div class="article-paragraph">中国国家卫生健康委员会官员郑忠伟上周五说，国务院批准了紧急使用方案之后，政府已“获得了世卫组织的理解和支持”。世卫组织的一名发言人周六表示，中国已发布了“国内紧急使用授权”，这种授权由各国自行决定，不需要世卫组织的批准。</div></div></div><div class="row article-dual-body-item"><div class="col-lg-6"><div class="article-paragraph">The vaccine candidates in Phase 3 trials have been previously tested on smaller groups of people. Phase 3 involves administering a candidate and a placebo to hundreds more, to see whether they are safe to take and effective in stopping the coronavirus. Roughly 100,000 people are involved in those trials, based on Chinese company disclosures. Virtually all of them are in other countries, however, because the coronavirus has been largely tamed in China.</div></div><div class="col-lg-6"><div class="article-paragraph">进入三期临床试验的候选疫苗以前已在更小的人群中做了试验。三期试验包括给数百人注射一种候选疫苗和一种安慰剂，以观察疫苗是否安全，是否能有效地预防新冠病毒。据公司披露的信息，大约有十万人参加了三期试验。但几乎所有参与者都在其他国家，因为中国已基本上控制住了新冠病毒的传播。</div></div></div><div class="row article-dual-body-item"><div class="col-lg-6"><div class="article-paragraph">Still, the Chinese government had already approved three vaccines for emergency use on others at home. In July, it said it would prioritize medical workers, epidemic prevention personnel, border inspection officials and people who “ensure basic city operations” to receive vaccines.</div></div><div class="col-lg-6"><div class="article-paragraph">尽管如此，中国政府已批准了三种在国内紧急使用的疫苗。政府曾在今年7月表示，将优先安排医务人员、防疫人员、边境口岸工作人员，以及“城市运行保障人员”接种疫苗。</div></div></div></div><div class="article-body-aside col-lg-3"></div></div><div class="big_ad" id="medium-rectangle-ad-2" data-target="{&quot;pos&quot;:&quot;mid3&quot;,&quot;adv&quot;:&quot;&quot;}"><small>广告</small></div><div class="article-partial"><div class="article-body-item col-lg-5"><div class="row article-dual-body-item"><div class="col-lg-6"><div class="article-paragraph">Now, it appears that those groups could be expanding.</div></div><div class="col-lg-6"><div class="article-paragraph">现在看来，优先接种的人群似乎正在扩大。<br></div></div></div><div class="row article-dual-body-item"><div class="col-lg-6"><div class="article-paragraph">This month, the government of Shaoyang, a city in Zhejiang Province, <a rel="noopener noreferrer" target="_blank" href="http://www.zjsycoop.com.cn/ckfinder/userfiles/files/20200910关于做好新冠病毒疫苗前期接种对象摸底工作的通知.pdf">asked local officials</a> to identify more people who could qualify as “emergency users.” People in schools, kindergartens and nursing homes were recommended for inclusion, as well as travelers heading to “medium- to high-risk areas.”</div></div><div class="col-lg-6"><div class="article-paragraph">本月，浙江省绍兴市政府<a rel="noopener noreferrer" target="_blank" href="http://www.zjsycoop.com.cn/ckfinder/userfiles/files/20200910关于做好新冠病毒疫苗前期接种对象摸底工作的通知.pdf">要求地方官员</a>对更多可能符合“紧急使用”的人群进行摸底。学校、幼儿园和养老院的人，以及前往“疫情中高风险”地区旅行的人都是重点推荐对象。</div></div></div><div class="row article-dual-body-item"><div class="col-lg-6"><div class="article-paragraph">Other government notices have asked local officials to identify people as candidates for getting vaccinations, though it was not always clear whether they would be inoculated before or after vaccines had cleared Phase 3 trials.</div></div><div class="col-lg-6"><div class="article-paragraph">其他的政府通知也要求地方官员对更多可能的接种对象进行登记，但不清楚这些人是在疫苗通过三期临床试验之前还是之后接种。<br></div></div></div><div class="row article-dual-body-item"><div class="col-lg-6"><div class="article-paragraph">Tough containment efforts appear to have tamed the virus in most parts of China. Still, outbreaks in Beijing and the far west in recent months have spooked the country’s leaders, who worry that lockdowns could disrupt the economic recovery. Chinese public health experts are also concerned that the arrival of winter and the need to keep people indoors might usher in another outbreak.</div></div><div class="col-lg-6"><div class="article-paragraph">中国大部分地区采取的严格限制措施似乎已经遏制住了病毒。尽管如此，最近几个月北京和西部偏远地区疫情的小规模暴发仍让中国领导人受惊，他们担心封城可能会扰乱经济复苏。中国的公共卫生专家们也担心，冬季的到来让人们需要呆在室内，这可能会引发新一轮疫情。<br></div></div></div><div class="row article-dual-body-item"><div class="col-lg-6"><div class="article-paragraph">A senior Chinese official said this month that a vaccine could be made available to the public as early as November. That same day, a spokeswoman for the United Arab Emirates’ Foreign Ministry said on Twitter that the government had authorized the Sinopharm vaccine to be given to its frontline workers after successful Phase 3 trials in the Emirates.</div></div><div class="col-lg-6"><div class="article-paragraph">中国一位高级官员本月表示，最早可能在11月向公众提供疫苗。同一天，阿拉伯联合酋长国外交部的一名发言人在Twitter上表示，在阿联酋成功进行了三期临床试验后，该国已批准一线工作人员接种国药集团的疫苗。<br></div></div></div><figure class="article-inline-photo large"><div class="img-box"><img src="../../../../../static01.nyt.com/images/2020/09/23/business/00china-vaccines-2/merlin_177104607_12c2b019-1a03-4b24-8091-3666653457b1-master1050.html" alt="科兴生物技术有限公司表示，几乎所有员工及其家人都接种了未经检验的疫苗。" data-src="../../../../../static01.nyt.com/images/2020/09/23/business/00china-vaccines-2/merlin_177104607_12c2b019-1a03-4b24-8091-3666653457b1-master1050.html"></div><figcaption><span>科兴生物技术有限公司表示，几乎所有员工及其家人都接种了未经检验的疫苗。</span> <cite>Tingshu Wang/Reuters</cite></figcaption></figure><div class="row article-dual-body-item"><div class="col-lg-6"><div class="article-paragraph">Raina MacIntyre, who heads the biosecurity program at the Kirby Institute of the University of New South Wales in Sydney, Australia, said she would not recommend the emergency use of vaccines before the conclusion of Phase 3 trials. AstraZeneca, the British-Swedish company, halted late-stage testing in the United States on a vaccine candidate this month <a href="https://www.nytimes.com/2020/09/08/health/coronavirus-astrazeneca-vaccine-safety.html">after one volunteer fell seriously ill</a> for unknown reasons.</div></div><div class="col-lg-6"><div class="article-paragraph">澳大利亚悉尼新南威尔士大学柯比研究所的生物安全项目负责人雷娜·麦金泰尔(Raina MacIntyre)说，她不建议在三期临床试验结束之前紧急使用疫苗。英国和瑞典合资的阿斯利康公司(AstraZeneca)本月因<a href="https://www.nytimes.com/2020/09/08/health/coronavirus-astrazeneca-vaccine-safety.html">一名志愿者患了原因不明的重病</a>，曾暂停其一种候选疫苗在美国的三期试验。</div></div></div><div class="row article-dual-body-item"><div class="col-lg-6"><div class="article-paragraph">Flawed vaccines can cause significant health problems. In 2017, <a href="https://www.nytimes.com/2017/12/17/health/sanofi-dengue-vaccine-philippines.html">children who were injected with Sanofi’s dengue vaccine became sicker.</a> Children vaccinated against respiratory syncytial virus, or R.S.V., in the 1960s also suffered side effects, resulting in trials being scrapped.</div></div><div class="col-lg-6"><div class="article-paragraph">有缺陷的疫苗会导致严重的健康问题。2017年，<a href="https://www.nytimes.com/2017/12/17/health/sanofi-dengue-vaccine-philippines.html">注射了赛诺菲(Sanofi)登革热疫苗的儿童被感染后病情更重</a>。20世纪60年代接种了防呼吸道合胞病毒疫苗的儿童也出现了副作用，导致试验取消。</div></div></div></div><div class="article-body-aside col-lg-3"></div></div><div class="big_ad" id="medium-rectangle-ad-3" data-target="{&quot;pos&quot;:&quot;mid4&quot;,&quot;adv&quot;:&quot;&quot;}"><small>广告</small></div><div class="article-partial"><div class="article-body-item col-lg-5"><div class="row article-dual-body-item"><div class="col-lg-6"><div class="article-paragraph">Broad inoculation campaigns also increase the risk of getting multiple vaccines, which could have adverse effects on a person’s immune response.</div></div><div class="col-lg-6"><div class="article-paragraph">大规模的接种运动也增加了接种多个同类疫苗的风险，这可能会对人体的免疫响应产生有害影响。<br></div></div></div><div class="row article-dual-body-item"><div class="col-lg-6"><div class="article-paragraph">“It may be three to six months before we get Phase 3 trial results — it’s not that long to wait,” Dr. MacIntyre said. “You are potentially muddying the waters for the time when we do have Phase 3 trial data for the best possible vaccine.”</div></div><div class="col-lg-6"><div class="article-paragraph"> “我们可能需要三到六个月就能得到三期试验的结果——等待的时间并不太长，”麦金泰尔说。“在我们得到最好疫苗的三期试验数据之前，目前的做法有搅浑水的可能。”</div></div></div><div class="row article-dual-body-item"><div class="col-lg-6"><div class="article-paragraph">Still, China may not want to wait.</div></div><div class="col-lg-6"><div class="article-paragraph">尽管如此，中国也许不想再等了。<br></div></div></div><div class="row article-dual-body-item"><div class="col-lg-6"><div class="article-paragraph">In an interview with China Central Television, the state broadcaster, Mr. Zheng, the health official, said that when cold weather arrived, the government might consider expanding the scope of who qualified for emergency use, adding people who work in markets, transportation and the service industry.</div></div><div class="col-lg-6"><div class="article-paragraph">在接受中国中央电视台采访时，卫健委官员郑忠伟说，寒冷天气到来时，政府可能会考虑扩大符合紧急使用条件的人群范围，把在市场、交通和服务行业工作的人员包括进来。<br></div></div></div><div class="row article-dual-body-item"><div class="col-lg-6"><div class="article-paragraph">“The goal is to first establish an immune barrier among special populations, so that the operations of the entire cities will have a stable guarantee,” Mr. Zheng said.</div></div><div class="col-lg-6"><div class="article-paragraph">“它的目的就是，在我们的特殊人群当中先建立一个免疫屏障，”郑忠伟说。“那么整个城市运行基本上就有了一个稳定的保障。”</div></div></div><div class="row article-dual-body-item"><div class="col-lg-6"><div class="article-paragraph">The vaccine makers and local governments stress that participation is voluntary, and many people who take the vaccines pay a considerable amount to do so. According to government notices, the vaccines would cost about $148, putting them out of reach for many in a country where <a rel="noopener noreferrer" target="_blank" href="https://www.scmp.com/economy/china-economy/article/3086678/china-rich-or-poor-nations-wealth-debate-muddied-conflicting">600 million people make that much in a month</a>.</div></div><div class="col-lg-6"><div class="article-paragraph">疫苗制造商和地方政府强调，接种疫苗是自愿的，而且许多接种者需要自己掏不少的钱。据政府的通知，疫苗的价格在1000元左右，对一个<a rel="noopener noreferrer" target="_blank" href="https://www.scmp.com/economy/china-economy/article/3086678/china-rich-or-poor-nations-wealth-debate-muddied-conflicting">六亿人口的月收入仅1000元</a>的国家来说，很多人都承担不起。</div></div></div></div><div class="article-body-aside col-lg-3"></div></div><div class="big_ad" id="medium-rectangle-ad-4" data-target="{&quot;pos&quot;:&quot;mid5&quot;,&quot;adv&quot;:&quot;&quot;}"><small>广告</small></div><div class="article-partial"><div class="article-body-item col-lg-5"><div class="row article-dual-body-item"><div class="col-lg-6"><div class="article-paragraph">It is not clear whether recipients have been fully warned about the risks of taking an unapproved vaccine.</div></div><div class="col-lg-6"><div class="article-paragraph">目前不清楚接种疫苗的人是否得到了接种未经检验疫苗风险的充分警告。<br></div></div></div><div class="row article-dual-body-item"><div class="col-lg-6"><div class="article-paragraph">Dr. Mulholland, of the Murdoch institute, said he would give an experimental coronavirus vaccine only to health care workers, especially in places like Brazil, which has one of the world’s highest case counts, and continue monitoring them. “They can be educated on the potential risks,” he said.</div></div><div class="col-lg-6"><div class="article-paragraph">默多克研究所的马尔霍兰说，他只会向医护人员提供实验性的新冠病毒疫苗，尤其是在巴西等全球确诊病例数很高的国家，并会对接种者进行持续观察。“医护人员可以接受潜在风险的教育，”他说。</div></div></div><figure class="article-inline-photo large"><div class="img-box"><img src="../../../../../static01.nyt.com/images/2020/09/23/business/00china-vaccines-3/merlin_172048464_cae9ab12-b11e-4d99-b268-f6f7b09aea37-master1050.html" alt="科兴生物技术公司在北京的一个实验室。" data-src="../../../../../static01.nyt.com/images/2020/09/23/business/00china-vaccines-3/merlin_172048464_cae9ab12-b11e-4d99-b268-f6f7b09aea37-master1050.html"></div><figcaption><span>科兴生物技术公司在北京的一个实验室。</span> <cite>Nicolas Asfouri/Agence France-Presse — Getty Images</cite></figcaption></figure><div class="row article-dual-body-item"><div class="col-lg-6"><div class="article-paragraph">Jerome Kim, head of the International Vaccine Institute, said he would like to know whether the Chinese authorities were following up on the vaccine recipients. He worries that people might engage in risky behavior if they believe they are protected by a vaccine of unknown efficacy.</div></div><div class="col-lg-6"><div class="article-paragraph">国际疫苗研究所(International Vaccine Institute)所长杰罗姆·金(Jerome Kim)说，他想知道中国当局是否在跟踪疫苗接种者的情况。他担心，如果人们认为自己受一种功效不明疫苗的保护，他们可能会有更危险的行为。<br></div></div></div><div class="row article-dual-body-item"><div class="col-lg-6"><div class="article-paragraph">“That has all sorts of negative consequences,” Dr. Kim said. “They could be infected and not know it, or they could be spreading the infection because they are relatively asymptomatic if the vaccine partially works.”</div></div><div class="col-lg-6"><div class="article-paragraph">“这会带来各种各样的负面后果，”金博士说。“他们可能感染了病毒但不知道，或者他们可能会传播感染，因为如果疫苗有部分效果的话，他们会相对来说没有症状。”<br></div></div></div><div class="row article-dual-body-item"><div class="col-lg-6"><div class="article-paragraph">That possibility seems not to have fazed many in China.</div></div><div class="col-lg-6"><div class="article-paragraph">这种可能性似乎并没有让很多中国人不安。<br></div></div></div><div class="row article-dual-body-item"><div class="col-lg-6"><div class="article-paragraph">On a recent Tuesday, Chen Deming, a former commerce minister, boasted to a trade and investment forum in Beijing that he did not need to wear a mask because he had taken a vaccine in Phase 3 trials. “Everybody, please relax,” he said, drawing laughter and applause from the audience.</div></div><div class="col-lg-6"><div class="article-paragraph">最近的一个周二，商务部前部长陈德铭在北京的一个贸易投资论坛上吹嘘说，他不需要戴口罩，因为他已经在一个三期试验中接种了疫苗。“大家放心，”他说，引发了听众中的笑声和掌声。</div></div></div><div class="row article-dual-body-item"><div class="col-lg-6"><div class="article-paragraph">Later, in an interview on the sidelines of the event, Mr. Chen, who turns 71 this year, said that his vaccine was developed by Sinopharm and that he had developed antibodies to protect against the coronavirus. He said a third of the Commerce Ministry’s staff had joined him in applying to receive the inoculation.</div></div><div class="col-lg-6"><div class="article-paragraph">后来在会议间隙接受采访时，今年将满71岁的陈德铭说，他接种的疫苗是国药集团研制的，自己已经产生了抵抗新冠病毒的抗体。他说，商务部有三分之一的工作人员和他一样申请了接种疫苗。</div></div></div><div class="row article-dual-body-item"><div class="col-lg-6"><div class="article-paragraph">“Because I go abroad sometimes, I applied to take it,” Mr. Chen told a New York Times reporter. Later, he added: “Do you want a shot, too?”</div></div><div class="col-lg-6"><div class="article-paragraph">“因为我有时候要出国，所以我就申请打了，”陈德铭对《世界经济观察报》的一名记者说。后来，他补问了一句：“你是不是也想打一下？”</div></div></div></div><div class="article-body-aside col-lg-3"></div></div></section></div><div class="col-lg-12 row author-info-container"><footer class="author-info"><p>Keith Bradsher对本文有报道贡献。Amber Wang、Claire Fu和Liu Yi对本文有研究贡献。</p><p>黄瑞黎(Sui-Lee Wee)是《世界经济观察报》北京分社记者。她报道中国近十年，关注社会议题、性别、基因监测、医疗保健以及人口和经济的交叉议题。欢迎在Twitter上关注她 <a rel="nofollow" target="_blank" href="https://twitter.com/suilee">@suilee</a>。</p><p>翻译：世界经济观察报中文网</p><p><a rel="nofollow" target="_blank" href="https://www.nytimes.com/2020/09/26/business/china-coronavirus-vaccine.html">点击查看本文英文版。</a></p></footer></div></article><div class="container article-footer"><div class="row"><div class="col-lg-12 dual-refer-cont"><div class="related-cont"><h4>相关报道</h4><ul class="refer-list"><li class="article-refer"><div class="refer-list-item"><a href="../../../20200911/china-vaccine-diplomacy/index.html" title="中国在全球推行新冠疫苗外交"><div><h3 class="refer-list-headline">中国在全球推行新冠疫苗外交</h3><p class="refer-pubdate">2020年9月11日</p></div><img alt="中国在全球推行新冠疫苗外交" src="../../../../../static01.nyt.com/images/2020/09/03/world/00vaccine-diplomacy-5/00vaccine-diplomacy-5-thumbLarge.jpg" width="75" height="75"></a></div></li><li class="article-refer"><div class="refer-list-item"><a href="#https://cn.nytimes.com/usa/20200907/coronavirus-vaccine-espionage/" title="新冠疫苗研发竞赛掀全球情报战"><div><h3 class="refer-list-headline">新冠疫苗研发竞赛掀全球情报战</h3><p class="refer-pubdate">2020年9月7日</p></div><img alt="新冠疫苗研发竞赛掀全球情报战" src="../../../../../static01.nyt.com/images/2020/09/06/us/politics/06dc-virus-intel-print/28dc-virus-intel1-sub-thumbLarge.jpg" width="75" height="75"></a></div></li><li class="article-refer"><div class="refer-list-item"><a href="../../../20200717/china-vaccine-coronavirus/index.html" title="中国在官方监管程序外测试新冠疫苗"><div><h3 class="refer-list-headline">中国在官方监管程序外测试新冠疫苗</h3><p class="refer-pubdate">2020年7月17日</p></div><img alt="中国在官方监管程序外测试新冠疫苗" src="../../../../../static01.nyt.com/images/2020/07/16/business/00virus-china-vaccine-sub/00virus-china-vaccine-sub-thumbLarge.jpg" width="75" height="75"></a></div></li><li class="article-refer"><div class="refer-list-item"><a href="../../../20200506/coronavirus-china-vaccine/index.html" title="中国的新冠疫苗研发能成功吗？"><div><h3 class="refer-list-headline">中国的新冠疫苗研发能成功吗？</h3><p class="refer-pubdate">2020年5月6日</p></div><img alt="中国的新冠疫苗研发能成功吗？" src="../../../../../static01.nyt.com/images/2020/05/01/business/00virus-china-vaccine-1/00virus-china-vaccine-1-thumbLarge.jpg" width="75" height="75"></a></div></li></ul></div></div><div class="col-lg-12"><div class="related hot_article"><h5 class="related-title">最受欢迎</h5><ol class="related-articles"><li><a href="#https://cn.nytimes.com/opinion/20220127/pakistan-united-states-china/?utm_source=top10-in-article&amp;utm_medium=articlepage&amp;utm_campaign=web"><article><h4>“巴铁”军方为什么想与中国保持距离？</h4><img alt="“巴铁”军方为什么想与中国保持距离？" src="../../../../../static01.nyt.com/images/2022/01/24/opinion/21Rafiq1/21Rafiq1-thumbLarge.jpg"></article></a></li><li><a href="#https://cn.nytimes.com/usa/20220127/computer-chip-shortage-taiwan/?utm_source=top10-in-article&amp;utm_medium=articlepage&amp;utm_campaign=web"><article><h4>战棋推演报告称台湾半导体工厂停产可能引发中美冲突</h4><img alt="战棋推演报告称台湾半导体工厂停产可能引发中美冲突" src="../../../../../static01.nyt.com/images/2022/01/26/us/politics/26dc-wargames/merlin_177315390_5fcf8532-e370-4f81-8f99-45c6c83044f4-thumbLarge.jpg"></article></a></li><li><a href="#https://cn.nytimes.com/opinion/20220126/china-covid-19/?utm_source=top10-in-article&amp;utm_medium=articlepage&amp;utm_campaign=web"><article><h4>中国追求“清零”将把国家置于灾难之中</h4><img alt="中国追求“清零”将把国家置于灾难之中" src="../../../../../static01.nyt.com/images/2022/01/25/opinion/25emanuel/25emanuel-thumbLarge.jpg"></article></a></li><li><a href="#https://cn.nytimes.com/sports/20220127/peng-shuai-china-australian-open/?utm_source=top10-in-article&amp;utm_medium=articlepage&amp;utm_campaign=web"><article><h4>澳网再现“彭帅在哪里”：球员和观赛者拒绝遗忘、为其发声</h4><img alt="澳网再现“彭帅在哪里”：球员和观赛者拒绝遗忘、为其发声" src="../../../../../static01.nyt.com/images/2022/01/26/sports/26aus-china1/merlin_199503951_9c695f25-2b8e-41b4-9c97-bf91de7aa190-thumbLarge.jpg"></article></a></li><li><a href="#https://cn.nytimes.com/usa/20220125/gang-chen-mit-china/?utm_source=top10-in-article&amp;utm_medium=articlepage&amp;utm_campaign=web"><article><h4>“我们在残害我们自己”：华裔教授陈刚案背后的愤怒与幻灭</h4><img alt="“我们在残害我们自己”：华裔教授陈刚案背后的愤怒与幻灭" src="../../../../../static01.nyt.com/images/2022/01/24/science/24CHEN-promo/24CHEN-promo-thumbLarge.jpg"></article></a></li><li><a href="#https://cn.nytimes.com/opinion/20220127/virtual-reality-simulation/?utm_source=top10-in-article&amp;utm_medium=articlepage&amp;utm_campaign=web"><article><h4>你可以开始相信，我们有可能会活在虚拟现实里</h4><img alt="你可以开始相信，我们有可能会活在虚拟现实里" src="../../../../../static01.nyt.com/images/2022/01/26/opinion/26manjoo-image/26manjoo-image-thumbLarge.jpg"></article></a></li><li><a href="#https://cn.nytimes.com/china/20220124/winter-olympics-china-beijing-xi-jinping/?utm_source=top10-in-article&amp;utm_medium=articlepage&amp;utm_campaign=web"><article><h4>不再取悦世界：一届展现习近平全面愿景的冬奥会</h4><img alt="不再取悦世界：一届展现习近平全面愿景的冬奥会" src="../../../../../static01.nyt.com/images/2022/01/13/world/00xi-olympics-30/00xi-olympics-30-thumbLarge.jpg"></article></a></li><li><a href="../../../20220126/imf-world-economic-report/indexf61c.html?utm_source=top10-in-article&amp;utm_medium=articlepage&amp;utm_campaign=web"><article><h4>国际货币基金组织称中美经济放缓将拖累全球经济</h4><img alt="国际货币基金组织称中美经济放缓将拖累全球经济" src="../../../../../static01.nyt.com/images/2022/01/25/multimedia/25global-econ-brf/25global-econ-brf-thumbLarge-v2.jpg"></article></a></li><li><a href="#https://cn.nytimes.com/asia-pacific/20220126/north-korea-launches-missiles-kim/?utm_source=top10-in-article&amp;utm_medium=articlepage&amp;utm_campaign=web"><article><h4>朝鲜突然频繁试射导弹传递了什么信息？</h4><img alt="朝鲜突然频繁试射导弹传递了什么信息？" src="../../../../../static01.nyt.com/images/2022/01/21/world/00nkorea-gameplan-01/00nkorea-gameplan-01-thumbLarge.html"></article></a></li><li><a href="#https://cn.nytimes.com/china/20220124/china-zero-covid-policy/?utm_source=top10-in-article&amp;utm_medium=articlepage&amp;utm_campaign=web"><article><h4>多地封锁引发沮丧与抱怨，中国“清零”政策还能走多远？</h4><img alt="多地封锁引发沮丧与抱怨，中国“清零”政策还能走多远？" src="../../../../../static01.nyt.com/images/2022/01/20/world/00virus-china-lockdown-01/00virus-china-lockdown-01-thumbLarge.html"></article></a></li></ol></div></div></div></div></div><footer class="row copy-footer">&copy; 2022 The World Economy Observer.<ul class="footerLinkList"><li class="footerLink"><a rel="nofollow" href="/ad/">广告</a></li><li class="footerLink"><a rel="nofollow" href="/about-us/">关于我们</a></li><li class="footerLink"><a rel="nofollow" href="/contact/">联系我们</a></li><li class="footerLink"><a rel="nofollow" href="/tos/">服务条款</a></li><li class="purr-content"></li></ul></footer><script src="/d1f1eryiqyjs0r.cloudfront.net/js/libs/require619b.js?v=f1810d8"></script><script src="/d1f1eryiqyjs0r.cloudfront.net/js/web/article.min619b.js?v=f1810d8"></script></main></body>
<!-- Mirrored from cn.nytimes.com/business/20200928/china-coronavirus-vaccine/dual/ by HTTrack Website Copier/3.x [XR&CO'2014], Fri, 28 Jan 2022 14:10:49 GMT -->
</html>